Anand Singh - NIH, NCI | 人才画像

基本信息

浏览量：12

职业迁徙

个人简介

Anand Singh currently works at the Center for Cancer Research, National Cancer Institute (USA). Anand does research in Virology, Molecular Biology and Cancer Research.

研究兴趣

论文共 97 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Role of Inflammasomes in Cancer Immunity: Mechanisms and Therapeutic Potential

Vivek Singh, Saba Ubaid, Mohammad Kashif, Tanvi Singh, Gaurav Singh,Roma Pahwa,Anand Singh

Journal of Experimental & Clinical Cancer Researchno. 1 (2025): 1-18

引用0浏览0WOS引用

Kinetically Controlled Polyelectrolyte Complex Assembly of Microrna-Peptide Nanoparticles Toward Treating Mesothelioma

Caleb F. Anderson,Anand Singh,Tyler Stephens,Chuong D. Hoang,Joel P. Schneider

Advanced Materialsno. 24 (2024)

引用2浏览0WOS引用

Supplementary Figure S5 from Epigenome Reprogramming Through H3K27 and H3K4 Trimethylation As a Resistance Mechanism to DNA Methylation Inhibition in BRAFV600E-Mutated Colorectal Cancer

Hey Min Lee,Ajay Kumar Saw,Van K. Morris,Stefania Napolitano,Christopher Bristow,Sanjana Srinivasan,Micheal Peoples,Alexey Sorokin,Preeti Kanikarla Marie,Jonathan Schulz,Anand K. Singh,Christopher Terranova,Oluwadara Coker,Abhinav Jain,Scott Kopetz,Kunal Rai

crossref（2024）

引用0浏览0引用

Supplementary Figure S4 from Epigenome Reprogramming Through H3K27 and H3K4 Trimethylation As a Resistance Mechanism to DNA Methylation Inhibition in BRAFV600E-Mutated Colorectal Cancer

crossref（2024）

引用0浏览0引用

Supplementary Figure S6 from Epigenome Reprogramming Through H3K27 and H3K4 Trimethylation As a Resistance Mechanism to DNA Methylation Inhibition in BRAFV600E-Mutated Colorectal Cancer

crossref（2024）

引用0浏览0引用

UNDERSTANDING PEDIATRIC BRAIN TUMOR CHEMOTHERAPY INDUCED LONG-TERM DEFICITS IN HIGH-ORDER NEUROCOGNITIVE AND SENSORIMOTOR FUNCTION

Anand Singh, Momo Harris,Rajasekaran Mahalingam,Kechen Ban, Renae Bertrand, Shungu Zimbwa, Khalil Ali Ahmad Kasm,Yuan Pan

NEURO-ONCOLOGY (2024)

引用0浏览0引用

BATF is a Major Driver of NK Cell Epigenetic Reprogramming and Dysfunction in AML

SCIENCE TRANSLATIONAL MEDICINE（2024）

引用0浏览0WOS引用

Supplementary Figure S7 from Epigenome Reprogramming Through H3K27 and H3K4 Trimethylation As a Resistance Mechanism to DNA Methylation Inhibition in BRAFV600E-Mutated Colorectal Cancer

crossref（2024）

引用0浏览0引用

Supplementary Figure S2 from Epigenome Reprogramming Through H3K27 and H3K4 Trimethylation As a Resistance Mechanism to DNA Methylation Inhibition in BRAFV600E-Mutated Colorectal Cancer

crossref（2024）

引用0浏览0引用

Enhancer Reprogramming Underlies Therapeutic Utility of a SMARCA2 Degrader in SMARCA4 Mutant Cancer

Sasikumar Kotagiri,Nicholas Blazanin,Yuanxin Xi, Yanyan Han, Md Qudratullah, Xiaobing Liang, Yawen Wang, Poonam Pandey,Hira Mazhar, Truong Nguyen Lam,Anand Kamal Singh,Jing Wang,Yonathan Lissanu

CELL CHEMICAL BIOLOGYno. 12 (2024)

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn